Viking Therapeutics Stock Analysis
| VKTX Stock | USD 27.82 0.50 1.77% |
Viking Therapeutics is undervalued with Real Value of 48.42 and Hype Value of 29.09. The main objective of Viking Therapeutics stock analysis is to determine its intrinsic value, which is an estimate of what Viking Therapeutics is worth, separate from its market price. There are two main types of Viking Therapeutics' stock analysis: fundamental analysis and technical analysis.
The Viking Therapeutics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Viking Therapeutics is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. Viking Stock trading window is adjusted to America/New York timezone.
Viking |
Viking Stock Analysis Notes
About 76.0% of the company outstanding shares are owned by institutional investors. The book value of Viking Therapeutics was at this time reported as 7.89. The company recorded a loss per share of 1.01. Viking Therapeutics had not issued any dividends in recent years. Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company was incorporated in 2012 and is headquartered in San Diego, California. Viking Thera operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people. For more information please call Brian Lian at 858 704 4660 or visit https://www.vikingtherapeutics.com.Viking Therapeutics Investment Alerts
| Viking Therapeutics generated a negative expected return over the last 90 days | |
| Viking Therapeutics has high historical volatility and very poor performance | |
| Net Loss for the year was (85.89 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Viking Therapeutics currently holds about 155.02 M in cash with (73.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.02. | |
| Viking Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Over 76.0% of the company outstanding shares are owned by institutional investors |
Viking Therapeutics Upcoming and Recent Events
Earnings reports are used by Viking Therapeutics to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 14th of February 2024 Upcoming Quarterly Report | View | |
| 24th of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 14th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Viking Therapeutics Thematic Classifications
In addition to having Viking Therapeutics stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | Pharmaceutical ProductsUSA Equities from Pharmaceutical Products industry as classified by Fama & French |
Viking Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.26 B.Technical Drivers
As of the 26th of February, Viking Therapeutics has the Coefficient Of Variation of (496.10), variance of 22.59, and Risk Adjusted Performance of (0.14). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Viking Therapeutics, as well as the relationship between them.Viking Therapeutics Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Viking Therapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Viking Therapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Viking Therapeutics Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Viking Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Viking Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Viking Therapeutics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Viking Therapeutics Outstanding Bonds
Viking Therapeutics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Viking Therapeutics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Viking bonds can be classified according to their maturity, which is the date when Viking Therapeutics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US92682RAA05 Corp BondUS92682RAA05 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Viking Therapeutics Predictive Daily Indicators
Viking Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Viking Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 258885.0 | |||
| Daily Balance Of Power | (0.23) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 28.27 | |||
| Day Typical Price | 28.12 | |||
| Price Action Indicator | (0.69) | |||
| Period Momentum Indicator | (0.50) | |||
| Relative Strength Index | 39.93 |
Viking Therapeutics Forecast Models
Viking Therapeutics' time-series forecasting models are one of many Viking Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Viking Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Viking Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Viking Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Viking shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Viking Therapeutics. By using and applying Viking Stock analysis, traders can create a robust methodology for identifying Viking entry and exit points for their positions.
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company was incorporated in 2012 and is headquartered in San Diego, California. Viking Thera operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Viking Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Price Transformation Now
Price TransformationUse Price Transformation models to analyze the depth of different equity instruments across global markets |
| All Next | Launch Module |
Additional Tools for Viking Stock Analysis
When running Viking Therapeutics' price analysis, check to measure Viking Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viking Therapeutics is operating at the current time. Most of Viking Therapeutics' value examination focuses on studying past and present price action to predict the probability of Viking Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viking Therapeutics' price. Additionally, you may evaluate how the addition of Viking Therapeutics to your portfolios can decrease your overall portfolio volatility.